Publication | Closed Access

Discovery of structure-based small molecular inhibitor of αB-crystallin against basal-like/triple-negative breast cancer development in vitro and in vivo

Molecular PharmacologyRadiation OncologyTumor BiologyBreast OncologyDrug TargetingNatural SciencesMolecular BiologyBreast CancerTumor TargetingAnti-cancer AgentBiomolecular EngineeringMedicineMolecular ModelingNovel TherapySmall MoleculesDrug Discovery